Clinical experiment designed to assess clinical efficacy targeting N/A in Lebanese patients. Primary outcome: prevalence and molecular characterization of neuromuscular disorders
This retrospective clinical study analyzed 20 years of clinical and molecular data from patients referred for neuromuscular disorder consultations in Lebanon (1999-2019). The study aimed to characterize the occurrence, frequency, and molecular basis of inherited neuromuscular disorders in the Lebanese population. Researchers reviewed clinical records and molecular diagnostic data from a multi-disciplinary neuromuscular consultation service, identifying 506 patients with 62 different neuromuscular disorders across 10 classes. The study included comprehensive molecular analysis identifying 103 variants in 49 genes. Special attention was given to the most prevalent conditions including spinal muscular atrophy (SMA), Duchenne and Becker muscular dystrophy, limb girdle muscular dystrophy, and Charcot-Marie-Tooth disease. The research also estimated disease incidence rates for the Lebanese population and compared findings with international literature. This work represents the first comprehensive overview of hereditary neuromuscular disorders in Lebanon, addressing a significant gap in regional clinical and epidemiological data.
Retrospective review of clinical and molecular data from multi-disciplinary neuromuscular consultations over 20-year period (1999-2019). Data collection included clinical diagnoses, molecular testing results, and genetic variant identification across multiple neuromuscular disorder categories.
Characterization of neuromuscular disorder prevalence and genetic variants in Lebanese population
Identification and classification of neuromuscular disorders with molecular confirmation where possible
No related hypotheses
No debates yet
No results recorded yet. Use POST /api/experiments/{id}/results to record a result.